Search global stocks & ETFs...Ctrl K

Learn Mode

RMD - Resmed Inc

394

$206.76

-$0.13 (-0.063%)

At market close

$206.77

$0.005 (0.002%)

After Hours 5/8/26, 8:38 PM

Score

4.36/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

RMD

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$29.99B

Industry

Health Care

EPS (TTM)

$10.42

P/E (TTM)

19.74

Div & Yield

$2.40 (1.16%)

FCF Payout Ratio

20.05%

P/S (TTM)

5.42

P/B

4.62

Diluted Shares

145.72M

Ex-Dividend

2026-05-14

Next Earnings

07-29

Forward P/E

17.76

Payout Ratio

22.91%

P/FCF (TTM)

17.27

FCF Yield

5.79%

Earnings Yield

5.07%

52 Week Range

Score Card

Explore Scores Tab

4.36

Very Good

Resmed Inc has grown revenue at 10.28% over the past year, which is strong growth. Also, it has more cash than current liabilities meaning it has enough cash to handle all its debts within the next year, if it wanted to.

Valuation Model

Key Score

2.00

Bad

Management

1.00

Very Bad

Growth

3.00

Average

Profitability

3.00

Average

Fin. Health

2.00

Bad

Dividends

2.00

Bad

Analyst

2.00

Bad

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

3 new filings were in the last 7 days

Filter Form Types

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-05-07 16:28:56

Form 3

Initial statement of beneficial ownership of securities - general instructions

Filed on 2026-05-04 18:05:55

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-04 17:55:12

Form 10-Q

General form for quarterly financial reports under Section 13 or 15(d)

Filed on 2026-04-30 18:19:39

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-30 16:10:25

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-30 16:06:30

Form SCHEDULE 13G

Unknown Form Type

Filed on 2026-04-29 15:12:11

Form SCHEDULE 13G

Unknown Form Type

Filed on 2026-04-29 10:43:46

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-09 11:44:13

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-04-07 16:13:09

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-03 07:29:26

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-02 13:52:28

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-04-25

High:

$362.25

75.2%

Avg:

$281.76

36.3%

Low:

$46.97

-77.3%

(% change is relative to the current stock price: $206.76)

Analyst Recommendations

Go to Analyst Tab

3.69

Good

15%

Strong Buy (4)

46%

Buy (12)

35%

Hold (9)

Sell (0)

Strong Sell (1)

About

Website
https://www.resmed.com/
Address
9001 Spectrum Center Blvd, San Diego CALIFORNIA, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=943819

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.

IPO Date

1995-06-01

Industry

Health Care

Total Employees

10,600

Exchange

New York Stock Exchange, Inc.

Reporting Currency

USD

GICS

Health Care Equipment & Supplies

GICS Sub

Health Care Equipment

GICS Sector

Health Care

GICS Group

Health Care Equipment & Services

RMD - Resmed Inc

394

$206.76

-$0.13 (-0.063%)

$206.77

$0.005 (0.002%)

4.36/5

Stock Unlock

Stock Profile

Score Card

Very Good

Insider Transactions

Market News

Form 144

Filed on 2026-05-07 16:28:56

Form 3

Filed on 2026-05-04 18:05:55

Form 4

Filed on 2026-05-04 17:55:12

Form 10-Q

Filed on 2026-04-30 18:19:39

Form 8-K

Filed on 2026-04-30 16:10:25

Form 8-K

Filed on 2026-04-30 16:06:30

Form SCHEDULE 13G

Filed on 2026-04-29 15:12:11

Form SCHEDULE 13G

Filed on 2026-04-29 10:43:46

Form 4

Filed on 2026-04-09 11:44:13

Form 144

Filed on 2026-04-07 16:13:09

Form 4

Filed on 2026-04-03 07:29:26

Form 4

Filed on 2026-04-02 13:52:28

Financials

Price Targets

75.2%

36.3%

-77.3%

Analyst Recommendations

About

Similar Stocks